As we previously announced, this session of Journal Club features Dr. Oliver Medvedik presenting a new study in which researchers claim that they have halved the epigenetic age of old rats using blood factors present in young rats.
In this panel discussion from Ending Age-Related Diseases 2020, Vadim Gladyshev of Harvard Medical School chairs a panel with Steve Horvath of UCLA, Kristen Fortney of BioAge Labs, Stanislav Skakun of Biodata, and Peter Fedichev of GERO to […]
An international collective of scientists has discovered a new cellular process: telomere transfer from antigen-presenting cells to T cells that boosts the latter’s lifespan and proliferative potential . T cells, an important element of our adaptive immune system, […]
Researchers have successfully used the CRISPR/Cas9 gene editing tool to destroy Ewing’s sarcoma and chronic myeloid leukemia tumor cells by targeting the fusion genes responsible for these tumors . Fusion genes, a […]
In his presentation at Ending Age-Related Diseases 2020, LEAF board member Javier Noris discussed the Longevity Impact Fund, the reasons why biotechnology funding has been lacking, the "valley of death" that must be crossed in order to fully fund early-stage research through the clinical trial process, and new ways in which venture capital can fund...
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have agreed to collaborate on […]